Child-Pugh score
Citation, DOI, disclosures and article data
At the time the article was created Yuranga Weerakkody had no recorded disclosures.
View Yuranga Weerakkody's current disclosuresAt the time the article was last revised Henry Knipe had the following disclosures:
- Micro-X Ltd, Shareholder (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Henry Knipe's current disclosures- Child-Turcotte-Pugh score
- Child-Turcotte-Pugh score in cirrhosis
- Child-Turcotte-Pugh criteria
The Child-Pugh score is a scoring system that measures the severity of chronic liver disease, including cirrhosis.
Usage
This score was initially devised by Child and Turcotte in 1964 to risk stratify patients with portal hypertension undergoing shunt surgery. It was revised in 1972 by Pugh with the replacement of nutritional status with the more objective INR/prothrombin 4,5. Subsequently, it has been a commonly used tool, along with the MELD score, to assess the prognosis of cirrhosis patients 5.
Higher Child-Pugh scores indicate worsening liver function and give treating teams an idea of "liver comorbidity" and "liver reserve". This can be useful when planning interventions on the liver since liver failure is the main cause of death after liver resection 1.
Classification
The score is composed of several categories:
-
total bilirubin, μmol/L (mg/dL)
<34: 1 point
34-50: 2 points
>50: 3 points
-
serum albumin, g/L
>35: 1 point
28-35: 2 points
<28: 3 points
-
INR or prothrombin time
<1.7 or <4: 1 point
1.7-2.3 or 4-6: 2 points
>2.3 or >6: 3 points
-
presence of ascites
none: 1 point
mild: 2 points
moderate to severe: 3 points
-
presence of hepatic encephalopathy
none: 1 point
grades I-II (or suppressed with medication): 2 points
grades III-IV (or refractory): 3 points
The point scores are then added up and classified as:
class A: 5-6 points
class B: 7-9 points
class C: 10-15 points
If the patient has primary biliary cholangitis or sclerosing cholangitis then bilirubin is classified as 2:
<68: 1 point
68–170: 2 points
>170: 3 points
References
- 1. Current Surgical Therapy: Expert Consult - Online and Print. (2013) - Google Books
- 2. Oh's Intensive Care Manual : Expert Consult: Online and Print. (2013) ISBN: 0702047627 - Google Books
- 3. Tsoris A & Marlar C. Use Of The Child Pugh Score In Liver Disease. 2025. - Pubmed
- 4. Ruf A, Dirchwolf M, Freeman R. From Child-Pugh to MELD Score and Beyond: Taking a Walk Down Memory Lane. Ann Hepatol. 2022;27(1):100535. doi:10.1016/j.aohep.2021.100535 - Pubmed
Incoming Links
Related articles: Pathology: Hepato-Pancreato-Biliary
- liver
- depositional disorders
- infection and inflammation
- liver abscess
- hepatic hydatid infection
- cirrhosis
- hepatitis
- cholecystitis
- cholangitis
- malignancy
- liver and intrahepatic bile duct tumours
- benign epithelial tumours
- hepatocellular hyperplasia
- hepatocellular adenoma
- hepatic/biliary cysts
- benign nonepithelial tumours
- primary malignant epithelial tumours
- hepatocellular carcinoma
- hepatocellular carcinoma variants
-
cholangiocarcinoma
- intra-hepatic
- mass-forming type
- periductal infiltrating type - Klatskin tumours
- intraductal growing type
- extra-hepatic/large duct type
- intra-hepatic
- biliary cystadenocarcinoma
- combined hepatocellular and cholangiocarcinoma
- hepatoblastoma
- undifferentiated carcinoma
- primary malignant nonepithelial tumours
- haematopoietic and lymphoid tumours
- primary hepatic lymphoma
- hepatic myeloid sarcoma (hepatic chloroma)
- secondary tumours
- miscellaneous
- adrenal rest tumours
- hepatic carcinosarcoma
- hepatic fibroma
- hepatic haemangioma
- hepatic Kaposi sarcoma
- hepatic lipoma
- hepatic mesenchymal hamartoma
- hepatic myxoma
- hepatic rhabdoid tumour
- hepatic solitary fibrous tumour
- hepatic teratoma
- hepatic yolk sac tumour
- inflammatory myofibroblastic tumour (inflammatory pseudotumour)
- nodular regenerative hyperplasia
- pancreatic rest tumours
- primary hepatic carcinoid
- benign epithelial tumours
- liver and intrahepatic bile duct tumours
- metabolic
- trauma
-
vascular and perfusion disorders
- portal vein related
- hepatic artery related
- hepatic veins related
- inferior vena cava related
- other
- third inflow
- liver thrombotic angiitis
- infra diaphragmatic total anomalous pulmonary venous return (TAPVR)
- hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu disease)
- pancreas
-
pancreatic neoplasms
- cystic neoplasm (cystic pancreatic mass differential diagnosis)
- solid neoplasm
- non-epithelial pancreatic neoplasms
- others
- simple pancreatic cyst
-
pancreatitis (mnemonic for the causes)
- acute pancreatitis
- chronic pancreatitis
- Ascaris-induced pancreatitis
- tropical pancreatitis
- autoimmune pancreatitis
- emphysematous pancreatitis
- hypertriglyceridaemia-induced pancreatitis
- hereditary pancreatitis
- pancreatitis associated with cystic fibrosis
- pancreaticopleural fistula
- segmental pancreatitis
- pancreatic atrophy
- pancreatic lipomatosis
- pancreatic trauma
- pancreatic transplant
-
pancreatic neoplasms
- gallbladder and biliary
- congenital malformations and anatomical variants
- gallstones
- gallbladder inflammation
- bile ducts inflammation
- gallbladder wall abnormalities
- other gallbladder abnormalities
- bile duct dilatation (differential)
- bile duct wall thickening (differential)
- bile ducts neoplasms